{"id":"NCT01173601","sponsor":"Eli Lilly and Company","briefTitle":"A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder","officialTitle":"A Randomized, Placebo-Controlled, Double-Blind Study of LY2216684 Fixed-Dose 12 Milligrams (mg) and 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-11","primaryCompletion":"2013-10","completion":"2013-10","firstPosted":"2010-08-02","resultsPosted":"2018-04-17","lastUpdate":"2018-04-17"},"enrollment":1416,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"LY2216684","otherNames":["Edivoxetine"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"SSRI","otherNames":["Selective Serotonin Reuptake Inhibitor"]}],"arms":[{"label":"12 milligrams (mg) LY2216684 + SSRI","type":"EXPERIMENTAL"},{"label":"18 milligrams (mg) LY2216684 + SSRI","type":"EXPERIMENTAL"},{"label":"Placebo + SSRI","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of this study is to assess whether at least 1 dose of LY2216684 (12 milligrams \\[mg\\] or 18 mg once daily) is superior to placebo once daily in the adjunctive treatment of participants with major depressive disorder (MDD) who were identified as partial responders to an adequate course of treatment with a selective serotonin reuptake inhibitor (SSRI) during an 8-week, double-blind, acute adjunctive treatment phase.","primaryOutcome":{"measure":"Change From Randomization to Week 8 in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score","timeFrame":"Randomization, 8 weeks","effectByArm":[{"arm":"12 mg LY2216684 + SSRI","deltaMin":-8.47,"sd":0.52},{"arm":"18 mg LY2216684 + SSRI","deltaMin":-8.7,"sd":0.53},{"arm":"Placebo + SSRI","deltaMin":-7.77,"sd":0.51}],"pValues":[{"comp":"OG000 vs OG002","p":"0.338"},{"comp":"OG001 vs OG002","p":"0.201"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":12},"locations":{"siteCount":63,"countries":["United States","Japan","Latvia","Poland","Russia","South Africa","Ukraine"]},"refs":{"pmids":["27685842","27035159"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":1413},"commonTop":["Headache","Nasopharyngitis","Dizziness","Nausea","Hyperhidrosis"]}}